Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I PK and safety study of oral OBE001 in pregnant women undergoing medically indicated pregnancy termination
NL-OMON40897Phase 1Withdrawn
- Sponsor
- ObsEva SA
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nolasiban in Preterm labor (PTL), sponsored by ObsEva SA. Primary endpoints: Maximum concentration, Area under the concentration-time curve to 24 hours and 7 more. Planned start Mar 2014; status: withdrawn.
02
Drugs
nolasiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NL-OMON40897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40897.